A phase I clinical trial on intratumoral injection of autologous CD1c (BDCA1)+/CD141 (BDCA3)+ myeloid dendritic cells (myDC) in combination with talimogene laherparepvec (TVEC) in patients with advanced pretreated melanoma
Talimogene Laherparepvec
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: A phase I clinical trial on intratumoral injection of autologous CD1c (BDCA1)+/CD141 (BDCA3)+ myeloid dendritic cells (myDC) in combination with talimogene laherparepvec (TVEC) in patients with advanced pretreated melanoma ### Output: Talimogene Laherparepvec